Matches in Nanopublications for { ?s ?p "[Established liver fibrosis patients had an improvement in necroinflammatory index after pirfenidone treatment when correlated with plasminogen activator inhibitor-1 and angiotensinogen-6 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[Established liver fibrosis patients had an improvement in necroinflammatory index after pirfenidone treatment when correlated with plasminogen activator inhibitor-1 and angiotensinogen-6 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP145356.RAUgCrLgxIIaZCHbR0aiEuRIs0EmsypFSfj3vXUgkz_8Q130_assertion description "[Established liver fibrosis patients had an improvement in necroinflammatory index after pirfenidone treatment when correlated with plasminogen activator inhibitor-1 and angiotensinogen-6 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP145356.RAUgCrLgxIIaZCHbR0aiEuRIs0EmsypFSfj3vXUgkz_8Q130_provenance.
- NP145323.RA3B65FaJJksf9faNecUFBpfainzgt0R4xy07OZHY0ITE130_assertion description "[Established liver fibrosis patients had an improvement in necroinflammatory index after pirfenidone treatment when correlated with plasminogen activator inhibitor-1 and angiotensinogen-6 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP145323.RA3B65FaJJksf9faNecUFBpfainzgt0R4xy07OZHY0ITE130_provenance.
- assertion description "[Established liver fibrosis patients had an improvement in necroinflammatory index after pirfenidone treatment when correlated with plasminogen activator inhibitor-1 and angiotensinogen-6 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP208463.RAuOM89Ce0z4XnE4L9TDxqRfq7FzrSPfv9Srmz_HkGQBI130_assertion description "[Established liver fibrosis patients had an improvement in necroinflammatory index after pirfenidone treatment when correlated with plasminogen activator inhibitor-1 and angiotensinogen-6 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208463.RAuOM89Ce0z4XnE4L9TDxqRfq7FzrSPfv9Srmz_HkGQBI130_provenance.
- NP242043.RAgDMMqoQzdl_dUxVh17zLBNwjbq-DSLErjn9h18BEVBs130_assertion description "[Established liver fibrosis patients had an improvement in necroinflammatory index after pirfenidone treatment when correlated with plasminogen activator inhibitor-1 and angiotensinogen-6 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP242043.RAgDMMqoQzdl_dUxVh17zLBNwjbq-DSLErjn9h18BEVBs130_provenance.
- NP208496.RA1bV2bj_lRj4OC9TUhphiTuEnxO8OYLuBHPsCGDG4ofo130_assertion description "[Established liver fibrosis patients had an improvement in necroinflammatory index after pirfenidone treatment when correlated with plasminogen activator inhibitor-1 and angiotensinogen-6 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208496.RA1bV2bj_lRj4OC9TUhphiTuEnxO8OYLuBHPsCGDG4ofo130_provenance.
- NP242044.RA9saBr6xPyihyh2H5lVAJ5piGzYhtVzoElO7ToXmVeMc130_assertion description "[Established liver fibrosis patients had an improvement in necroinflammatory index after pirfenidone treatment when correlated with plasminogen activator inhibitor-1 and angiotensinogen-6 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP242044.RA9saBr6xPyihyh2H5lVAJ5piGzYhtVzoElO7ToXmVeMc130_provenance.